Insulin Lispro

• Insulin lispro is a rapid‑acting insulin analog used to manage blood glucose in diabetes mellitus.
• Type 1 diabetes mellitus: improves post‑prandial glucose control.
• Type 2 diabetes mellitus: assists in achieving glycemic targets when oral agents are insufficient.
• Diabetic ketoacidosis: used as part of insulin therapy to correct severe hyperglycemia.

• Insulin lispro binds to the insulin receptor on cell membranes, activating the receptor’s intrinsic tyrosine kinase activity. This triggers downstream signaling pathways that promote translocation of GLUT‑4 transporters to the cell surface, enhancing glucose uptake in muscle and adipose tissue while suppressing hepatic glucose production, resulting in rapid reduction of blood glucose levels.

Insulin lispro may cause a range of adverse reactions, from mild to serious.

Common Side Effects

• Hypoglycemia: low blood sugar episodes, especially if meals are missed.
• Injection site reactions: redness, swelling, or itching at the injection site.
• Weight gain: modest increase due to improved glucose utilization.
• Lipodystrophy: localized changes in fat tissue with repeated injections.
• Nausea or gastrointestinal discomfort.

Serious or Rare Side Effects

• Severe hypoglycemia: prolonged or unconscious episodes requiring assistance.
• Anaphylactic reaction: rare but potentially life‑threatening allergy.
• Insulin allergy: systemic rash, urticaria, or angioedema.
• Hypokalemia: low potassium levels, particularly with high insulin doses.
• Edema: fluid retention leading to swelling of extremities.

• When using insulin lispro, several safety considerations are important.
• Dose individualization: adjust dose based on blood glucose monitoring and carbohydrate intake.
• Blood glucose monitoring: frequent checks are essential to avoid hypoglycemia.
• Renal or hepatic impairment: may require dose reduction and closer observation.
• Concurrent hypoglycemia: avoid dosing if patient is already experiencing low blood sugar.
• Pregnancy and lactation: use only if benefits outweigh potential risks, under specialist guidance.
• Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Insulin lispro can interact with other medicines, affecting glucose control.

Major Interactions (Avoid)

• Sulfonylureas: additive hypoglycemic effect.
• Meglitinides: increased risk of severe hypoglycemia.
• Alcohol: potentiates insulin’s glucose‑lowering action.

Moderate Interactions (Monitor Closely)

• Beta‑blockers: may mask hypoglycemia symptoms.
• ACE inhibitors: can enhance insulin sensitivity.
• Corticosteroids: may raise blood glucose, requiring dose adjustment.
• Thyroid hormones: may alter insulin requirements.
• Oral contraceptives: possible modest effect on insulin dose.